No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir-Ritonavir in Healthy Subjects without HIV Infection : A Placebo-Controlled Trial. Commentary

No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir-Ritonavir in Healthy Subjects without HIV Infection : A Placebo-Controlled Trial. Commentary

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2008, Vol.47 (4), p.567-576
Hauptverfasser: DUBE, Michael P, CHANGYU SHEN, GREENWALD, Martha, MATHER, Kieren J, GRUNFELD, Carl
Format: Artikel
Sprache:eng
Schlagworte:
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
Human viral diseases
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infectious diseases
Medical sciences
Pharmacology. Drug treatments
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1058-4838
1537-6591